Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001713070-26-000002

Director sold 5,740 shares at $25.12 ($144,189)

  • Director acquired 7,751 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

SULIMAN SHEHNAAZ · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-14 Grant or award : show line 1 in the form 10b5-1 +7,751 33,691 D
2026-05-18 Sale : show line 2 in the form 10b5-1 −5,740 $25.12 $144,189 27,951 D
Open-market sales · 5,740 sh · avg $25.12 · $144,189

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-14 Grant or award : show line 3 in the form 10b5-1 Stock Option (Right to Buy) +14,058 14,058 D
Loading xslF345X06/ownership.xml…